Stratec SE
XETRA:SBS
Stratec SE
XETRA:SBS
Price:
43.7 EUR
0.81%
Market Closed
Updated:
May 16, 2024
Stratec SE
Research & Development
|
Stratec SE
Research & Development Peer Comparison
Comparables:
AFX
EUZ
SHL
DRW8
SRT
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Stratec SE
XETRA:SBS
|
Research & Development
-€9.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-6%
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Research & Development
-€356.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Research & Development
-€4.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Research & Development
-€1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Research & Development
-€319.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Sartorius AG
XETRA:SRT
|
Research & Development
-€170m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-14%
|
See Also
What is Stratec SE's Research & Development?
Research & Development
-9.5m
EUR
-9.5m
EUR
Based on the financial report for Mar 31, 2024, Stratec SE's Research & Development amounts to -9.5m EUR.
What is Stratec SE's Research & Development growth rate?
Research & Development CAGR 10Y
-6%
-6%
Over the last year, the Research & Development growth was -38%.
You don't have any saved screeners yet
